{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:11:45Z","timestamp":1783606305075,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41440-024-02037-3","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T07:11:52Z","timestamp":1733382712000},"page":"1012-1023","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hypertension awareness, treatment, control, and prognosis: insights from the sub-cohort of China PEACE million persons project"],"prefix":"10.1038","volume":"48","author":[{"given":"Weida","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"2037_CR1","unstructured":"World Health Organization. Global report on hypertension: the race against a silent killer. 2023; p. 1\u2013276."},{"key":"2037_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957\u201380.","journal-title":"Lancet"},{"key":"2037_CR3","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","volume":"82","author":"GA Mensah","year":"2023","unstructured":"Mensah GA, Fuster V, Murray CJL, Roth GA. Global burden of cardiovascular diseases and risks, 1990\u20132022. J Am Coll Cardiol. 2023;82:2350\u2013473.","journal-title":"J Am Coll Cardiol"},{"key":"2037_CR4","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/S0140-6736(19)30955-9","volume":"394","author":"P Geldsetzer","year":"2019","unstructured":"Geldsetzer P, Manne-Goehler J, Marcus ME, Ebert C, Zhumadilov Z, Wesseh CS, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1\u00b71 million adults. Lancet. 2019;394:652\u201362.","journal-title":"Lancet"},{"key":"2037_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(19)31145-6","volume":"394","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2019","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394:639\u201351.","journal-title":"Lancet"},{"key":"2037_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1056\/NEJMoa2208391","volume":"389","author":"AS Desai","year":"2023","unstructured":"Desai AS, Webb DJ, Taubel J, Casey S, Cheng Y, Robbie GJ, et al. Zilebesiran, an RNA interference therapeutic agent for hypertension. N. Engl J Med. 2023;389:228\u201338.","journal-title":"N. Engl J Med"},{"key":"2037_CR7","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1001\/jama.2023.16029","volume":"330","author":"LJ Laffin","year":"2023","unstructured":"Laffin LJ, Rodman D, Luther JM, Vaidya A, Weir MR, Rajicic N, et al. Aldosterone synthase inhibition with lorundrostat for uncontrolled hypertension: the target-HTN randomized clinical trial. JAMA. 2023;330:1140\u201350.","journal-title":"JAMA"},{"key":"2037_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.122.20853","volume":"80","author":"G Sesa-Ashton","year":"2023","unstructured":"Sesa-Ashton G, Nolde JM, Muente I, Carnagarin R, Lee R, Macefield VG, et al. Catheter-based renal denervation: 9-year follow-up data on safety and blood pressure reduction in patients with resistant hypertension. Hypertension. 2023;80:811\u20139.","journal-title":"Hypertension"},{"key":"2037_CR9","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","volume":"395","author":"M B\u00f6hm","year":"2020","unstructured":"B\u00f6hm M, Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder RE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020;395:1444\u201351.","journal-title":"Lancet"},{"key":"2037_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0140-6736(24)01028-6","volume":"404","author":"J Liu","year":"2024","unstructured":"Liu J, Li Y, Ge J, Yan X, Zhang H, Zheng X, et al. Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial. Lancet. 2024;404:245\u201355.","journal-title":"Lancet"},{"key":"2037_CR11","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"SPRINT Research G, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A randomized trial of intensive versus standard blood-pressure control. N. Engl J Med. 2015;373:2103\u201316.","journal-title":"N. Engl J Med"},{"key":"2037_CR12","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","volume":"385","author":"W Zhang","year":"2021","unstructured":"Zhang W, Zhang S, Deng Y, Wu S, Ren J, Sun G, et al. Trial of intensive blood-pressure control in older patients with hypertension. N. Engl J Med. 2021;385:1268\u201379.","journal-title":"N. Engl J Med"},{"key":"2037_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08190-0","volume":"22","author":"MA Peters","year":"2022","unstructured":"Peters MA, Noonan CM, Rao KD, Edward A, Alonge OO. Evidence for an expanded hypertension care cascade in low- and middle-income countries: a scoping review. BMC Health Serv Res. 2022;22:827.","journal-title":"BMC Health Serv Res"},{"key":"2037_CR14","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41591-023-02769-8","volume":"30","author":"DT Stein","year":"2024","unstructured":"Stein DT, Reitsma MB, Geldsetzer P, Agoudavi K, Aryal KK, Bahendeka S, et al. Hypertension care cascades and reducing inequities in cardiovascular disease in low- and middle-income countries. Nat Med. 2024;30:414\u201323.","journal-title":"Nat Med"},{"key":"2037_CR15","doi-asserted-by":"publisher","first-page":"e010200","DOI":"10.1136\/bmjopen-2015-010200","volume":"6","author":"J Lu","year":"2016","unstructured":"Lu J, Xuan S, Downing NS, Wu C, Li L, Krumholz HM, et al. Protocol for the China PEACE (patient-centered evaluative assessment of cardiac events) million persons project pilot. BMJ Open. 2016;6:e010200.","journal-title":"BMJ Open"},{"key":"2037_CR16","doi-asserted-by":"publisher","first-page":"e016195","DOI":"10.1136\/bmjopen-2017-016195","volume":"7","author":"M Su","year":"2017","unstructured":"Su M, Zhang Q, Lu J, Li X, Tian N, Wang Y, et al. Protocol for a nationwide survey of primary health care in China: the China PEACE (patient-centered evaluative assessment of cardiac events) MPP (million persons project) primary health care survey. BMJ Open. 2017;7:e016195.","journal-title":"BMJ Open"},{"key":"2037_CR17","first-page":"182","volume":"16","author":"Joint Committee for Guideline Revision.","year":"2019","unstructured":"Joint Committee for Guideline Revision. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension\u2014a report of the Revision Committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol Jgc 2019;16:182\u2013241.","journal-title":"J Geriatr Cardiol Jgc"},{"key":"2037_CR18","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874\u20132071.","journal-title":"J Hypertens"},{"key":"2037_CR19","first-page":"e484","volume":"138","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation. 2018;138:e484\u2013594.","journal-title":"Circulation"},{"key":"2037_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jacasi.2023.09.003","volume":"4","author":"A Cai","year":"2024","unstructured":"Cai A, Chen C, Wang J, Ou Y, Nie Z, Feng Y. Social determinants of health, cardiovascular health, and outcomes in community-dwelling adults without cardiovascular disease. JACC Asia. 2024;4:44\u201354.","journal-title":"JACC Asia"},{"key":"2037_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377\u201399.","journal-title":"Stat Med"},{"key":"2037_CR22","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/S2214-109X(22)00428-4","volume":"11","author":"T Zhou","year":"2023","unstructured":"China PEACE Collaborative G, Zhou T, Wang Y, Zhang H, Wu C, Tian N, et al. Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional study. Lancet Glob Health. 2023;11:e83\u201394.","journal-title":"Lancet Glob Health"},{"key":"2037_CR23","doi-asserted-by":"publisher","first-page":"e071952","DOI":"10.1136\/bmj-2022-071952","volume":"380","author":"M Zhang","year":"2023","unstructured":"Zhang M, Shi Y, Zhou B, Huang Z, Zhao Z, Li C, et al. Prevalence, awareness, treatment, and control of hypertension in China, 2004\u201318: findings from six rounds of a national survey. BMJ. 2023;380:e071952.","journal-title":"BMJ"},{"key":"2037_CR24","doi-asserted-by":"publisher","first-page":"757481","DOI":"10.3389\/fpubh.2022.757481","volume":"10","author":"C Yan","year":"2022","unstructured":"Yan C, Yuan Y, Zhao D, Li J, Fu P, Chen Y, et al. Family doctor contract services and awareness of blood pressure measurement among hypertension patients: a cross-sectional study in rural Shandong, China. Front Public Health. 2022;10:757481.","journal-title":"Front Public Health"},{"key":"2037_CR25","doi-asserted-by":"publisher","first-page":"e1001490","DOI":"10.1371\/journal.pmed.1001490","volume":"10","author":"W Maimaris","year":"2013","unstructured":"Maimaris W, Paty J, Perel P, Legido-Quigley H, Balabanova D, Nieuwlaat R, et al. The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med. 2013;10:e1001490.","journal-title":"PLoS Med"},{"key":"2037_CR26","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/S0140-6736(22)00325-7","volume":"399","author":"Y Sun","year":"2022","unstructured":"Sun Y, Mu J, Wang DW, Ouyang N, Xing L, Guo X, et al. A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial. Lancet. 2022;399:1964\u201375.","journal-title":"Lancet"},{"key":"2037_CR27","doi-asserted-by":"crossref","unstructured":"Guo X, Ouyang N, Sun G, Zhang N, Li Z, Zhang X, et al. Multifaceted intensive blood pressure control model in older and younger individuals with hypertension: a randomized clinical trial. JAMA Cardiology. 2024;9:781\u201390.","DOI":"10.1001\/jamacardio.2024.1449"},{"key":"2037_CR28","doi-asserted-by":"publisher","first-page":"e736","DOI":"10.1016\/S2214-109X(18)30259-6","volume":"6","author":"T Beaney","year":"2018","unstructured":"Beaney T, Schutte AE, Tomaszewski M, Ariti C, Burrell LM, Castillo RR, et al. May measurement month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health. 2018;6:e736\u201343.","journal-title":"Lancet Glob Health"},{"key":"2037_CR29","doi-asserted-by":"publisher","first-page":"iii23","DOI":"10.1093\/eurheartjsupp\/suae039","volume":"26","author":"X Chen","year":"2024","unstructured":"Chen X, Hu Z, Lei CB, Zheng QD, Wang XL, Beaney T, et al. May measurement month 2021: an analysis of blood pressure screening results from China. Eur Heart J Suppl J Eur Soc Cardiol. 2024;26:iii23\u20136.","journal-title":"Eur Heart J Suppl J Eur Soc Cardiol"},{"key":"2037_CR30","doi-asserted-by":"publisher","first-page":"e0292159","DOI":"10.1371\/journal.pone.0292159","volume":"18","author":"Z Fan","year":"2023","unstructured":"Fan Z, Yang C, Zhang J, Huang Y, Yang Y, Zeng P, et al. Trends and influence factors in the prevalence, awareness, treatment, and control of hypertension among US adults from 1999 to 2018. PloS One. 2023;18:e0292159.","journal-title":"PloS One"},{"key":"2037_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.753070","volume":"9","author":"Y Cao","year":"2021","unstructured":"Cao Y, Sathish T, Haregu T, Wen Y, Mello GT, Kapoor N, et al. Factors associated with hypertension awareness, treatment, and control among adults in Kerala, India. Front Public Health. 2021;9:753070.","journal-title":"Front Public Health"},{"key":"2037_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09862-4","volume":"20","author":"A Santosa","year":"2020","unstructured":"Santosa A, Zhang Y, Weinehall L, Zhao G, Wang N, Zhao Q, et al. Gender differences and determinants of prevalence, awareness, treatment and control of hypertension among adults in China and Sweden. BMC Public Health. 2020;20:1763.","journal-title":"BMC Public Health"},{"key":"2037_CR33","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.4070\/kcj.2020.0208","volume":"50","author":"YW Jeon","year":"2020","unstructured":"Jeon YW, Kim HC. Factors associated with awareness, treatment, and control rate of hypertension among Korean young adults aged 30\u201349 years. Korean Circ J. 2020;50:1077\u201391.","journal-title":"Korean Circ J"},{"key":"2037_CR34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1161\/HYPERTENSIONAHA.122.20061","volume":"80","author":"H Ma","year":"2023","unstructured":"Ma H, Liu F, Li J, Chen J, Cao J, Chen S, et al. Sex differences in associations between socioeconomic status and incident hypertension among Chinese adults. Hypertension. 2023;80:783\u201391.","journal-title":"Hypertension"},{"key":"2037_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.puhe.2024.06.005","volume":"235","author":"W Qiu","year":"2024","unstructured":"Qiu W, Cai A, Nie Z, Wang J, Ou Y, Feng Y. Age and sex differences in the impact of common comorbidities on stroke and myocardial infarction: results from the China patient-centered evaluative assessment of cardiac events million persons project. Public Health. 2024;235:119\u201327.","journal-title":"Public Health"},{"key":"2037_CR36","doi-asserted-by":"publisher","first-page":"e968","DOI":"10.1016\/S2468-2667(23)00244-X","volume":"8","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Wang Y, Shrikant B, Tse LA, Zhao Y, Liu Z, et al. Socioeconomic disparity in mortality and the burden of cardiovascular disease: analysis of the Prospective Urban Rural Epidemiology (PURE)-China cohort study. Lancet Public Health. 2023;8:e968\u2013e977.","journal-title":"Lancet Public Health"},{"key":"2037_CR37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","volume":"34","author":"JR Petrie","year":"2018","unstructured":"Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34:575\u201384.","journal-title":"Can J Cardiol"},{"key":"2037_CR38","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1161\/HYPERTENSIONAHA.121.17981","volume":"78","author":"G Jia","year":"2021","unstructured":"Jia G, Sowers JR. Hypertension in diabetes: an update of basic mechanisms and clinical disease. Hypertension. 2021;78:1197\u2013205.","journal-title":"Hypertension"},{"key":"2037_CR39","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","volume":"51","author":"GP Rossi","year":"2008","unstructured":"Rossi GP, Bolognesi M, Rizzoni D, Seccia TM, Piva A, Porteri E, et al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension. 2008;51:1366\u201371.","journal-title":"Hypertension"},{"key":"2037_CR40","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jacc.2021.01.014","volume":"77","author":"N Fatani","year":"2021","unstructured":"Fatani N, Dixon DL, Van Tassell BW, Fanikos J, Buckley LF. Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension. J Am Coll Cardiol. 2021;77:1290\u20139.","journal-title":"J Am Coll Cardiol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-02037-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-02037-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-02037-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T10:01:44Z","timestamp":1750672904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-02037-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2037"],"URL":"https:\/\/doi.org\/10.1038\/s41440-024-02037-3","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Guangzhou Provincial People\u2019s Hospital (No. GDREC2016438H(R2)). All participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement"}}]}}